Obtaining Paediatric SPC Extensions in the European Union
This article was originally published in SRA
Executive Summary
New European Union legislation on paediatric data requirements for marketing authorisation applications came into effect in January 2007. Among other things, the so-called Paediatric Regulation offers a reward for conducting paediatric trials: a six-month extension to the supplementary protection certificate. In this article, we look at the details of the regulation (Regulation (EC) No 1901/2006)1, how companies should go about gaining the SPC extension and some of the pitfalls they may encounter along the way.
You may also be interested in...
J&J Has A Plan B If Gamechanger Single Dose Vaccine Disappoints
If J&J’s gamble on a single dose pays off, it could rapidly advance the fight against SARS-CoV2 – but a second study will provide a safety net.
Woodcock To Be Acting US FDA Commissioner; Sharfstein Tops Biden's List Of Candidates For Post
Agency has been prepping Woodcock for the temporary task but what will happen to her role on Operation Warp Speed remains unclear. The move should give Biden team cushion to confirm a permanent leader of whom a top contender is former senior FDA staffer Joshua Sharfstein, a proponent of drug reforms that may irk manufacturers.
Health And Wellness Trademark Review 12 January, 2021
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: